Agrin promotes the proliferation, invasion and migration of rectal cancer cells via the WNT signaling pathway to contribute to rectal cancer progression

References

• Fan M, Wang Gao YS. Circular RNA circMTO1 acts as an antitumor factor in rectal cancer cell lines by downregulation of miR-19b-3p. 2019. [Online ahead of print].
   Google Scholar
• Mu JF, Wang XD, Sun PD. Expression of miR-31 in rectal cancer patients and its effect on proliferation ability of rectal cancer cells SW837. Eur Rev Med Pharmacol Sci. 2018;22:8675–8681.
   PubMed Web of Science ®Google Scholar
• Wan P, Bai X, Yang C, et al. miR-129-5p inhibits proliferation, migration, and invasion in rectal adenocarcinoma cells through targeting E2F7. J Cell Physiol. 2020;235(7–8):5689–5701.
   PubMed Web of Science ®Google Scholar
• Marcos-Gragera R, Mallone S, Kiemeney LA, et al.; EUROCARE-5 Working Group. Urinary tract cancer survival in Europe 1999-2007: results of the population-based study EUROCARE-5. Eur J Cancer. 2015;51(15):2217–2230.
   PubMed Web of Science ®Google Scholar
• De Rosa M, Pace U, Rega D, et al. Genetics, diagnosis and management of colorectal cancer (Review). Oncol Rep. 2015;34(3):1087–1096.
   PubMed Web of Science ®Google Scholar
• Qu W, Huang W, Yang F, et al. Long noncoding RNA LINC00461 mediates cisplatin resistance of rectal cancer via miR-593-5p/CCND1 axis. Biomed Pharmacother. 2020;124:109740.
   PubMed Web of Science ®Google Scholar
• Bezakova G, Ruegg MA. New insights into the roles of agrin. Nat Rev Mol Cell Biol. 2003;4(4):295–308.
   PubMed Web of Science ®Google Scholar
• Tátrai P, Dudás J, Batmunkh E, et al. Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma. Lab Invest. 2006;86(11):1149–1160.
   PubMed Web of Science ®Google Scholar
• Gautam M, Noakes PG, Moscoso L, et al. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell. 1996;85(4):525–535.
   PubMed Web of Science ®Google Scholar
• Zhang QJ, Wan L, Xu HF, Department of Oncology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine. High expression of agrin is associated with tumor progression and poor prognosis in hepatocellular carcinoma. Math Biosci Eng. 2019;16(6):7375–7383.
   PubMed Web of Science ®Google Scholar
• Kawahara R, Granato DC, Carnielli CM, et al. Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma. PLoS One. 2014;9(12):e115004.
   PubMed Web of Science ®Google Scholar
• Klein-Scory S, Kübler S, Diehl H, et al. Immunoscreening of the extracellular proteome of colorectal cancer cells. BMC Cancer. 2010;10:70.
   PubMed Web of Science ®Google Scholar
• Brody H. Colorectal cancer. Nature. 2015;521(7551):S1.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tian S, Li X, et al. UBE2C promotes rectal carcinoma via miR-381. Cancer Biol Ther. 2018;19(3):230–238.
   PubMed Web of Science ®Google Scholar
• Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15(12):1243–1253.
   PubMed Web of Science ®Google Scholar
• van Kempen LC, Ruiter DJ, van Muijen GN, et al. The tumor microenvironment: a critical determinant of neoplastic evolution. Eur J Cell Biol. 2003;82(11):539–548.
   PubMed Web of Science ®Google Scholar
• Iozzo RV, Sanderson RD. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med. 2011;15(5):1013–1031.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Lakshmanan M, Swa HL, et al. An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma. Nat Commun. 2015;6:6184.
   PubMed Web of Science ®Google Scholar
• Edwards IJ. Proteoglycans in prostate cancer. Nat Rev Urol. 2012;9(4):196–206.
   PubMed Web of Science ®Google Scholar
• Mundhenke C, Meyer K, Drew S, et al. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol. 2002;160(1):185–194.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Njah K, Pobbati AV, et al. Agrin as a mechanotransduction signal regulating YAP through the *Hippo pathway. Cell Rep. 2017;18(10):2464–2479.
   PubMed Web of Science ®Google Scholar
• Li D, Gu Q, Xie Z, et al. Clinical significance of nuclear localisation of agrin in lung adenocarcinoma. PJP. 2019;70(3):198–204.
   Google Scholar
• Rivera C, Zandonadi FS, Sánchez-Romero C, et al. Agrin has a pathological role in the progression of oral cancer. Br J Cancer. 2018;118(12):1628–1638.
   PubMed Web of Science ®Google Scholar
• Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 2012;4:a008052.
   PubMed Web of Science ®Google Scholar
• Sareddy GR, Pratap UP, Viswanadhapalli S, et al. PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling. Neurooncol Adv. 2019;1(1):vdz042.
   PubMedGoogle Scholar
• Han L, Yan Y, Zhao L, et al. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway. 2020;24(11):6242–6252.
   Google Scholar
• Li B, Guo X, Li N, et al. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway. Cell Oncol (Dordr). 2020;43(3):489–503.
   PubMed Web of Science ®Google Scholar
• Shao Q, Xu J, Deng R, et al. SNHG 6 promotes the progression of colon and rectal adenocarcinoma via miR-101-3p and Wnt/β-catenin signaling pathway. BMC Gastroenterol. 2019;19:163.
   PubMed Web of Science ®Google Scholar
• Wu SM, Tsai WS, Chiang SF, et al. Comprehensive transcriptome profiling of Taiwanese colorectal cancer implicates an ethnic basis for pathogenesis. Sci Rep. 2020;10(1):4526.
   PubMed Web of Science ®Google Scholar
• Yu J, Liu D, Sun X, et al. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression. Cell Death Dis. 2019;10(1):26.
   PubMedGoogle Scholar
• Rahmani F, Avan A, Hashemy SI, et al. Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer. J Cell Physiol. 2018;233(2):811–817.
   PubMed Web of Science ®Google Scholar
• Ghosh N, Hossain U, Mandal A, et al. The Wnt signaling pathway: a potential therapeutic target against cancer. Ann N Y Acad Sci. 2019;1443(1):54–74.
   PubMed Web of Science ®Google Scholar
• Li T, Lai Q, Wang S, et al. MicroRNA-224 sustains Wnt/β-catenin signaling and promotes aggressive phenotype of colorectal cancer. J Exp Clin Cancer Res. 2016;29(35):21.
   PubMed Web of Science ®Google Scholar